| Genetic basis for clinical response to CTLA-4 blockade in melanoma A Snyder, V Makarov, T Merghoub, J Yuan, JM Zaretsky, A Desrichard, ... New England Journal of Medicine 371 (23), 2189-2199, 2014 | 4520 | 2014 |
| Molecular determinants of response to anti–programmed cell death (PD)-1 and anti–programmed death-ligand 1 (PD-L1) blockade in patients with non–small-cell lung cancer profiled … H Rizvi, F Sanchez-Vega, K La, W Chatila, P Jonsson, D Halpenny, ... Journal of clinical oncology 36 (7), 633-641, 2018 | 1248 | 2018 |
| Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome G Girardi, J Berman, P Redecha, L Spruce, JM Thurman, D Kraus, ... The Journal of clinical investigation 112 (11), 1644-1654, 2003 | 810 | 2003 |
| The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset CJ Ceol, Y Houvras, J Jane-Valbuena, S Bilodeau, DA Orlando, V Battisti, ... Nature 471 (7339), 513-517, 2011 | 624 | 2011 |
| Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learning NF Greenwald, G Miller, E Moen, A Kong, A Kagel, T Dougherty, ... Nature biotechnology 40 (4), 555-565, 2022 | 475 | 2022 |
| INI1-deficient tumors: diagnostic features and molecular genetics TJ Hollmann, JL Hornick The American journal of surgical pathology 35 (10), e47-e63, 2011 | 411 | 2011 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 398 | 2020 |
| Adipocyte-derived lipids mediate melanoma progression via FATP proteins M Zhang, JS Di Martino, RL Bowman, NR Campbell, SC Baksh, ... Cancer discovery 8 (8), 1006-1025, 2018 | 281 | 2018 |
| PRAME expression in melanocytic tumors C Lezcano, AA Jungbluth, KS Nehal, TJ Hollmann, KJ Busam The American journal of surgical pathology 42 (11), 1456-1465, 2018 | 279 | 2018 |
| Emergence of a high-plasticity cell state during lung cancer evolution ND Marjanovic, M Hofree, JE Chan, D Canner, K Wu, M Trakala, ... Cancer cell 38 (2), 229-246. e13, 2020 | 260 | 2020 |
| Alternative transcription initiation leads to expression of a novel ALK isoform in cancer T Wiesner, W Lee, AC Obenauf, L Ran, R Murali, QF Zhang, EWP Wong, ... Nature 526 (7573), 453-457, 2015 | 242 | 2015 |
| Regulatory role of C5a in LPS‐induced IL‐6 production by neutrophils during sepsis NC Riedemann, RF Guo, TJ Hollmann, H Gao, TA Neff, JS Reuben, ... The FASEB journal 18 (2), 1-16, 2004 | 231 | 2004 |
| Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock J Kildsgaard, TJ Hollmann, KW Matthews, K Bian, F Murad, RA Wetsel The Journal of Immunology 165 (10), 5406-5409, 2000 | 222 | 2000 |
| Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer JM Chan, A Quintanal-Villalonga, VR Gao, Y Xie, V Allaj, O Chaudhary, ... Cancer cell 39 (11), 1479-1496. e18, 2021 | 210 | 2021 |
| The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation JM Taube, G Akturk, M Angelo, EL Engle, S Gnjatic, S Greenbaum, ... Journal for immunotherapy of cancer 8 (1), 2020 | 200 | 2020 |
| Metastasis and immune evasion from extracellular cGAMP hydrolysis J Li, MA Duran, N Dhanota, WK Chatila, SE Bettigole, J Kwon, RK Sriram, ... Cancer discovery 11 (5), 1212-1227, 2021 | 182 | 2021 |
| Whole slide imaging equivalency and efficiency study: experience at a large academic center MG Hanna, VE Reuter, MR Hameed, LK Tan, S Chiang, C Sigel, ... Modern Pathology 32 (7), 916-928, 2019 | 180 | 2019 |
| Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy A Jiménez-Sánchez, P Cybulska, KLV Mager, S Koplev, O Cast, ... Nature Genetics 52 (6), 582-593, 2020 | 164 | 2020 |
| Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial LJ Padrón, DM Maurer, MH O’Hara, EM O’Reilly, RA Wolff, ZA Wainberg, ... Nature medicine 28 (6), 1167-1177, 2022 | 161 | 2022 |
| Digital fibromyxoma (superficial acral fibromyxoma): a detailed characterization of 124 cases TJ Hollmann, JVMG Bovée, CDM Fletcher The American journal of surgical pathology 36 (6), 789-798, 2012 | 157 | 2012 |
